The binding modes of some non-platinum metal anticancer complexes, Cp2TiCI2, Cp2ZrCI2, 
These results should be valuable in understanding the mechanism of antitumor activity, as well as laying the foundation for rational design of more active and less toxic metal drugs.
In this paper, we present the reactions of some typical antitumor agents, CpTiCI (Cp= q -CsH), CpZrCI, cis-Ru"CI(DMSO) (DMSO) (cis-RDT), (CH)SnCI, (CH)_SnCI and (CH5)2SnCl(phen) (phen=Phenanthroline), with DNA and its components, and report their coordination chemistry investigations in aqueous solution with nucleotides, as well as their bindings to DNA under near physiological condition. The possible molecular mechanism modes of action are investigated and discussed as well as some rules of binding modes-activity relationships of metal antitumor drugs are inferred and discussed.
Experimental
The antitumor agents CpTiCI(TDC), cis-RDT, (CH)SnCI, (CH)SnCI and (CH)SnCl(phen) were prepared and purified according to the literature methods , CpZrCI2 and (CH)SnCI, were purchased from Aldrich Chemical Company. The NMR recognition probe, [trans-enOs( q -H)](CFSO) ,was a generous gift from Professor H. Taube and Dr. Zaiwei Li, Stanford University, CA, the nucleotides, 2'-deoxyguanosine-5'-monophosphat (dGMP), adenosine-5'-monophosphate (AMP) were purchased from Sigma Chemical Company. Ethidium bromide(EthBr) was obtained from Fluca(Buchs, Switzerland). All other reagents and solvents were analytical reagents grades.
H,P NMR spectra were recorded on a Bruker AM-500MHz NMR spectrometer or a VXR-300 MHz NMR spectrometer in DO, proton chemical shifts are referenced to DSS as internal standard, and phosphorous chemical shifts are referenced to 85% HPO as external standard. UV and CD spectra were recorded on a Shimadzu UV-365 spectrophotometer and a JASCO J-500C spectrophotometer using l cm quartz cuvette. The fluorescence spectra were performed on a Hitachi Model-850 spectra fluorometer using 1 cm quartz cuvette, excitation wave length was set at 520 nm. The entrance and exit monochromator slit widths were adjusted to 0.5 nm. All pH measurements were carried out on a Beckman 50 pH meter. All reported When dGMP was added to solution of the probe in D20 at 25C each solute at 0.01 moll L, the phosphate oxygen and N of dGMP both coordinated to the probe, the former being dynamically preferred (K=3 1) and the interaction was complete after 10 min, while the latter is thermodynamically preferred (K=2.9 10) and binding was complete after 24h. Figure 1 Interaction of Some Non In the ternary system of cis-Ru (DMSO)CI2-probe-GMP (Fig.3a, b) both of the peaks due to the phosphate binding and Nz binding diminished obviously in intensity after 10 min (Fig.3a) and 24h compared with those of the GMP-probe binary system. This indicate that both phosphate oxygen and Nz of dGMP are coordinated to Ru. As diorganotin agents, both fresh prepared and old prepared (has been prepared for three months) solutions of Et2SnCI2 were used. In the ternary system of Et2SnCI2(fresh)-probedGMP (Fig.4a, b) , the case is just the same as that in Cp2ZrCI2-probe-dGMP trinary system.
f''*"'l"-"""-I When old Et2SnCI2 is used in place of fresh Et2SnCI2 (Fig.5a, b UV spectra Figure 7 shows the absorption spectra of DNA alone in the presence of CpTiCI with various concentration in 0.1 mol/L NaCI(pH=7.2) after they reacted in dark at 37C for 48h ( So that the binding modes with DNA of a metal complex seem play a key role in its anticancer activity. It seems all highly active anticancer metal drugs has the ability to bind with both phosphate group and nitrogen sites on bases of DNA. As everybody knows, chemical activities of a compound are determined by its molecular structure. So we should make further analysis on the relationships between the structure of metal anticancer agents, the binding modes with DNA and their anticancer activities.
DNAs are the target molecules for most of the metal anticancer agents in human body. The anticancer nature is the coordination of metal ions with DNA molecules, i.e. the direct chelation of the metal ions with certain nucleophilic groups in DNA (such as oxygen sites from phosphates and nitrogen as well as oxygen sites from bases), causing the DNAs' damage in cancer cells, the DNAs were hindered during the processes of replication or transcription, the growing and division of the cancer cells were stopped, and resulted in their death.
When drug molecules (pre-anticancer molecules) enter into an organism, they will first undergo a series of processes including hydrolysis, transport and membrane-crossing, and then reach the nearby of target DNA molecule and form active intermediates which interact with DNA molecules directly and exert the anticancer activity. These active intermediates have a general cis-form of two-water-binding transitional state:
[ciS-AnM(H20)2]m/, A is stably binding hydrophobic group, n=l, 2 or more; M is metal ion, The number of water molecules binding to M must not be fewer than two and they must be lie in the ortho-position of the structure
The functions of the hydrophobic ligand A are: (1) caring the whole molecule to cross membranes (including cell membranes and nucleus membranes), go through the bilipid bilayers; (2) The above TPCP has generalized the molecular structure, action modes and steric selectivity for metal anticancer agents. This principle has some guidance for the design and synthesis of new metal antitumor drugs. However, for numerous various metal antitumor complexes, the action mechanisms may differ dramatically, and there are always some complex can't be accorded with the TPC Principle. And the TPC Principle itself may still has some incomplete aspects, and need to be further studied to make it more complete.
